Takuya Sugita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Takuya Sugita has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Haruna Sato
NOV Academic Research, TOKIWA Pharmaceutical Co. Ltd. Minato‐ku Tokyo Japan
1 shared publication - Hiroshi Matsunaka
NOV Academic Research Tokiwa Pharmaceutical Co., Ltd. Tokyo Japan
1 shared publication - Hiroshi Takayanagi
Department of Immunology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan
1 shared publication - Hung Hiep Huynh
Division of Molecular Pathology, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan
1 shared publication - Katsuko Kikuchi
Department of Dermatology Tohoku University Graduate School of Medicine Sendai Japan
1 shared publication - Kazuo Okamoto
Department of Osteoimmunology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan
1 shared publication
Latest Publications
- Open Access
- 17 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (29) , eaec7827
A distinct antigen presentation pathway drives potent T cell immunity in lipid nanoparticle–based mRNA vaccines
Lipid nanoparticle–encapsulated mRNA (mRNA-LNP) vaccines trigger the potent differentiation of antigen-specific cytotoxic CD8 T cells in addition to antibody production. Despite its high immunogenicity, the cellular mechanisms by which mRNA-LNP induces such unusual immune responses remain largely unclear. Here, we show that mRNA-LNP induces potent and long-lasting CD8 T cell expansion through an antigen presentation mechanism that differs from that of conventional adjuvants. In mice immunized with mRNA-LNP, the number of antigen-specific CD8 T cells was one order of magnitude higher than that induced by combining antigen proteins with immunostimulants such as lipopolysaccharide or polyinosinic:polycytidinic acid. Intramuscularly administered mRNA-LNPs were mainly taken up by migratory type 2 conventional dendritic cells in draining lymph nodes, resulting in notably strong and persistent antigen presentation through major histocompatibility complex class I. Furthermore, CD8 T cell induction by mRNA-LNP required migratory dendritic cells but not the traditional cross-presentation pathway that is otherwise essential for antiviral and antitumor immunity. Thus, the mRNA-LNP formulation exerts unconventional immune responses through a different antigen-presentation pathway from conventional component vaccines.
- 17 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (29) , eaec7827
Open AccessA distinct antigen presentation pathway drives potent T cell immunity in lipid nanoparticle–based mRNA vaccines
Lipid nanoparticle–encapsulated mRNA (mRNA-LNP) vaccines trigger the potent differentiation of antigen-specific cytotoxic CD8 T cells in addition to antibody production. Despite its high immunogenicity, the cellular mechanisms by which mRNA-LNP induces such unusual immune responses remain largely unclear. Here, we show that mRNA-LNP induces potent and long-lasting CD8 T cell expansion through an antigen presentation mechanism that differs from that of conventional adjuvants. In mice immunized with mRNA-LNP, the number of antigen-specific CD8 T cells was one order of magnitude higher than that induced by combining antigen proteins with immunostimulants such as lipopolysaccharide or polyinosinic:polycytidinic acid. Intramuscularly administered mRNA-LNPs were mainly taken up by migratory type 2 conventional dendritic cells in draining lymph nodes, resulting in notably strong and persistent antigen presentation through major histocompatibility complex class I. Furthermore, CD8 T cell induction by mRNA-LNP required migratory dendritic cells but not the traditional cross-presentation pathway that is otherwise essential for antiviral and antitumor immunity. Thus, the mRNA-LNP formulation exerts unconventional immune responses through a different antigen-presentation pathway from conventional component vaccines.
- Open Access
- 10 February 2026
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 25 (2) , e70707
Atopic Dermatitis Accelerates Skin Physiological Functional Decline and Visible Aging, Suppressed by Skincare Habits
Background: Atopic dermatitis (AD) is an inflammatory skin disorder that causes barrier dysfunction and chronic itching; patients exhibit more obvious age‐related external changes than healthy individuals. Detailed comparative investigations of patients with AD and healthy individuals are lacking, including visible age, skin physiological function, and inflammatory and immune factors in the stratum corneum. Aims: To investigate the skin physiological function, physiologically active substances in the stratum corneum, and visible age of patients with AD and healthy controls (HCs), and to verify the effects of skincare habits. Methods: This study was conducted from November to December 2023 and included male and female patients with AD and HCs aged 20–50 years. Skincare habits were assessed using a questionnaire, physiological function by device measurements, physiologically active substances using multiplex analysis, and visible aging by comparison with age‐ and sex‐matched patients with AD and HCs. Results: Compared with those in the HC group, the cheek skin of the AD group was darker, had a higher melanin index, lower stratum corneum water content, higher transepidermal water loss, higher levels of inflammatory and immune factors in the stratum corneum, and less sebum on the forehead skin surface. Additionally, the AD group appeared older than their age‐matched HC group. However, skincare habits improved these changes, with no significant difference between the HC and AD groups following skincare habits. Conclusions: Skincare habits can suppress AD‐associated changes in the physiological function of the skin, inflammatory and immune factors in the stratum corneum, and visible aging.
- 10 February 2026
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 25 (2) , e70707
Open AccessAtopic Dermatitis Accelerates Skin Physiological Functional Decline and Visible Aging, Suppressed by Skincare Habits
Background: Atopic dermatitis (AD) is an inflammatory skin disorder that causes barrier dysfunction and chronic itching; patients exhibit more obvious age‐related external changes than healthy individuals. Detailed comparative investigations of patients with AD and healthy individuals are lacking, including visible age, skin physiological function, and inflammatory and immune factors in the stratum corneum. Aims: To investigate the skin physiological function, physiologically active substances in the stratum corneum, and visible age of patients with AD and healthy controls (HCs), and to verify the effects of skincare habits. Methods: This study was conducted from November to December 2023 and included male and female patients with AD and HCs aged 20–50 years. Skincare habits were assessed using a questionnaire, physiological function by device measurements, physiologically active substances using multiplex analysis, and visible aging by comparison with age‐ and sex‐matched patients with AD and HCs. Results: Compared with those in the HC group, the cheek skin of the AD group was darker, had a higher melanin index, lower stratum corneum water content, higher transepidermal water loss, higher levels of inflammatory and immune factors in the stratum corneum, and less sebum on the forehead skin surface. Additionally, the AD group appeared older than their age‐matched HC group. However, skincare habits improved these changes, with no significant difference between the HC and AD groups following skincare habits. Conclusions: Skincare habits can suppress AD‐associated changes in the physiological function of the skin, inflammatory and immune factors in the stratum corneum, and visible aging.